• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Device-guided breathing not associated with improved blood pressure control

byShayna BejaimalandJames Jiang
September 17, 2014
in Cardiology, Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Device-guided breathing was not associated with improved blood pressure as compared to active controls such as sham devices or music therapy.

2. Device guided breathing exercises may be a costly alternative to freely available relaxation techniques that may be equally efficacious.

Evidence Rating Level: 2 (Good)

Study Rundown: Given the negative impact of long-standing hypertension on cardiovascular health, it is important to discover effective pharmacological and non-pharmacological interventions. Newer approaches include slowing of breathing through device-guided breathing (DGB) exercises. These devices use musical tones to train one to slow their breathing. Previous studies have shown small short-term effects against inactive controls. However, this study sought to investigate the DGB’s efficacy against active controls, such as musical therapy and sham devices.

This meta-analysis did not find a significant association between office blood pressure improvements within their primary and secondary analyses of individual patient data and data from published articles. Overall risk of bias analysis determined that the two studies initiated by the manufacturer of the DGB device had a high risk of selective outcome reporting, as the primary outcome was analyzed with methods not determined a priori. Strengths of the study include using statistical meta-analytic techniques to re-analyze individual patient level data from single or double blinded RCTs, and also comparing DGB to active controls. However, the study was limited to lower quality RCTs with short follow-up. Consequently, no long-term cardiovascular end points were analyzed, and two of five studies were found to have a high risk of bias.

Click to read the study in JAMA Internal Medicine

Relevant Reading: Device-guided breathing exercises in the control of human blood pressure: systematic review and meta-analysis

RELATED REPORTS

Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease

Baxdrostat reduces blood pressure in previously treatment-resistant hypertension

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

In-Depth [meta-analysis]: This meta-analysis identified five RCTs that were either single or double-blinded and compared DGB to active controls (sham device or music therapy). Four studies compared DGB to music therapy and one to a sham device. The commercial DGB device, called RESPeRATE, was used in all five RCTs, two of which were conducted by RESPeRATE’s manufacturer, Inter-Cure Ltd. The primary outcome was a change in office systolic blood pressure between baseline and end of treatment period. The secondary outcome was a change in diastolic pressure. Ideally, the primary analysis would include all individual patient data from all studies. However, for studies where this data could not be attained, secondary meta-analysis would include the study’s published unadjusted data.

The primary analysis, when corrected for study group, age, sex and body mass index, showed non-significant mean differences in inverse variance (95% CI) of 1.7 mmHg (-3.1 to 6.5) in favour of the control for systolic blood pressure and -0.7 mmHg (-3.6 to 2.1) in favour of the DGB for diastolic blood pressure. When the two additional positive manufacturer studies were included in the secondary analysis, the non-significant results remained with a mean difference in inverse variance (95% CI) of 1.1 (-2.8 to 5.0) in favour of DGB. Additionally, when specifically compared to music therapy, DGB did not significantly lower systolic or diastolic blood pressure, with differences of 1.8 mm Hg (-2.8 to 6.3) in favour of DGB and 1.6 mmHg (-2.3 to 5.4) in favour of DGB.

More from this author: Overall US diet quality improved from 1999 to 2010, Arterial catheter monitoring in ICU not associated with mortality benefit

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

 

Tags: blood pressure
Previous Post

Antenatal magnesium sulfate may not improve pediatric neurodevelopment

Next Post

Fecal transplantation in recurrent C. difficile infection [Classics Series]

RelatedReports

Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Intensive blood pressure lowering by non-physician healthcare providers significantly reduces the risk of cardiovascular disease

March 30, 2023
UTI associated with increased risk of preeclampsia
Cardiology

Baxdrostat reduces blood pressure in previously treatment-resistant hypertension

February 9, 2023
Preterm birth associated with cardiovascular risk factors in adolescence
Cardiology

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

January 4, 2023
Improved glycemic control in type 1 diabetics on very low-carbohydrate diets
Cardiology

Patient-supporter training improved patient confidence in managing diabetes

December 23, 2022
Next Post
Classics Series, Landmark Trials in Medicine

Fecal transplantation in recurrent C. difficile infection [Classics Series]

TASTE trial: Thrombus aspiration before PCI in STEMI does not reduce mortality

TASTE trial: Thrombus aspiration before PCI in STEMI does not reduce mortality

Most anticoagulants for venous thromboembolism similarly effective

Most anticoagulants for venous thromboembolism similarly effective

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Childhood maltreatment may cause mental health problems
  • #VisualAbstract: Hydrochlorothiazide does not impact risk of kidney-stone recurrence
  • Metformin use may decrease risk of osteoarthritis development
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options